Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Somatoform Disorders × Clear all

Phase

Phase NA 3 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 134 Neoplasms 112 Polycystic Ovary Syndrome 66 Prostatic Neoplasms 63 Colorectal Neoplasms 51 Carcinoma, Non-Small-Cell Lung 46 Pain 40 Carcinoma, Hepatocellular 35 Lung Neoplasms 34 Keratosis, Actinic 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Neoplasm Metastasis 26 Head and Neck Neoplasms 26 Pain, Postoperative 25 Stomach Neoplasms 24 Colonic Neoplasms 23 Multiple Myeloma 22 Brain Neoplasms 21 Pancreatic Neoplasms 20 Lymphoma, Follicular 19 Leukemia 19 Anemia 19 Uterine Cervical Neoplasms 18 Leukemia, Myeloid, Acute 18 Infertility 18 Leiomyoma 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Carcinoma, Renal Cell 15

Interventions

dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03348696 2020-01-09

REaCT-TAPS

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms, Somatoform Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡